Diagnosis of Celiac Disease

Gastrointestinal Endoscopy Clinics of North America

Volumn 22, Issue 4, 2012, Pages 661-677

  Lebwohl, Benjamin ^a   Rubio Tapia, Alberto ^b   Assiri, Asaad ^c   Newland, Catherine ^d   Guandalini, Stefano ^c,d  

^a Columbia University ^*  (United States)

^b MAYO CLINIC   (United States)

^c KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Celiac disease; Esophagogastroduodenoscopy; Population screening; Undiagnosed celiac disease

Indexed keywords

ENDOMYSIUM ANTIBODY; GLIADIN ANTIBODY; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ABDOMINAL PAIN; ANTIBODY BLOOD LEVEL; BLOATING; CELIAC DISEASE; CLINICAL PRACTICE; CONSTIPATION; DEAMINATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIARRHEA; DUODENUM BIOPSY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGOGASTRODUODENOSCOPY; FALSE POSITIVE RESULT; FOLLOW UP; GENETIC SCREENING; GENOTYPE; HAPLOTYPE; HEARTBURN; HISTOPATHOLOGY; HUMAN; NAUSEA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEROPREVALENCE;

ANTIBODIES; AUTOANTIBODIES; BIOPSY; CELIAC DISEASE; ENDOSCOPY, DIGESTIVE SYSTEM; GENETIC TESTING; HLA-DQ ANTIGENS; HUMANS; INTESTINE, SMALL; MASS SCREENING;

EID: 84867676134     PISSN: 10525157     EISSN: 15581950     Source Type: Journal    
DOI: 10.1016/j.giec.2012.07.004     Document Type: Review

References (95)

1. Murray J.A., Van Dyke C., Plevak M.F., et al. Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol 2003, 1:19-27.
2. Green P.H., Neugut A.I., Naiyer A.J., et al. Economic benefits of increased diagnosis of celiac disease in a national managed care population in the United States. J Insur Med 2008, 40:218-228.
3. Fasano A., Berti I., Gerarduzzi T., et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003, 163:286-292.
4. Rubio-Tapia A., Kyle R.A., Kaplan E.L., et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009, 137:88-93.
5. Katz K.D., Rashtak S., Lahr B.D., et al. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol 2011, 106:1333-1339.
6. Catassi C., Kryszak D., Bhatti B., et al. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med 2010, 42:530-538.
7. Catassi C., Fabiani E., Ratsch I.M., et al. The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr Suppl 1996, 412:29-35.
8. Virta L.J., Kaukinen K., Collin P. Incidence and prevalence of diagnosed coeliac disease in Finland: results of effective case finding in adults. Scand J Gastroenterol 2009, 44:933-938.
9. Fasano A. Should we screen for coeliac disease? Yes. BMJ 2009, 339:b3592.
10. Ludvigsson J.F., Montgomery S.M., Ekbom A., et al. Small-intestinal histopathology and mortality risk in celiac disease. JAMA 2009, 302:1171-1178.
11. Hershcovici T., Leshno M., Goldin E., et al. Cost effectiveness of mass screening for coeliac disease is determined by time-delay to diagnosis and quality of life on a gluten-free diet. Aliment Pharmacol Ther 2010, 31:901-910.
12. Shamir R., Hernell O., Leshno M. Cost-effectiveness analysis of screening for celiac disease in the adult population. Med Decis Making 2006, 26:282-293.
13. Long K.H., Rubio-Tapia A., Wagie A.E., et al. The economics of coeliac disease: a population-based study. Aliment Pharmacol Ther 2010, 32:261-269.
14. Leffler D.A., Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol 2010, 105:2520-2524.
15. Metzger M.H., Heier M., Maki M., et al. Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989-1998. Eur J Epidemiol 2006, 21:359-365.
16. Canavan C., Logan R.F., Khaw K.T., et al. No difference in mortality in undetected coeliac disease compared with the general population: a UK cohort study. Aliment Pharmacol Ther 2011, 34:1012-1019.
17. Lohi S., Maki M., Rissanen H., et al. Prognosis of unrecognized coeliac disease as regards mortality: a population-based cohort study. Ann Med 2009, 41:508-515.
18. Johnston S.D., Watson R.G., McMillan S.A., et al. Coeliac disease detected by screening is not silent-simply unrecognized. QJM 1998, 91:853-860.
19. Godfrey J.D., Brantner T.L., Brinjikji W., et al. Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology 2010, 139:763-769.
20. Tio M., Cox M.R., Eslick G.D. Meta-analysis: coeliac disease and the risk of all-cause mortality, any malignancy and lymphoid malignancy. Aliment Pharmacol Ther 2012, 35:540-551.
21. Sharaiha R.Z., Lebwohl B., Reimers L., et al. Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008. Cancer 2011, [Epub ahead of print]. 10.1002/cncr.26700.
22. Vilppula A., Kaukinen K., Luostarinen L., et al. Clinical benefit of gluten-free diet in screen-detected older celiac disease patients. BMC Gastroenterol 2011, 11:136.
23. Catassi C., Kryszak D., Louis-Jacques O., et al. Detection of celiac disease in primary care: a multicenter case-finding study in North America. Am J Gastroenterol 2007, 102:1454-1460.
24. Green P.H., Cellier C. Celiac disease. N Engl J Med 2007, 357:1731-1743.
25. Chin R.L., Sander H.W., Brannagan T.H., et al. Celiac neuropathy. Neurology 2003, 60:1581-1585.
26. Gabrielli M., Cremonini F., Fiore G., et al. Association between migraine and celiac disease: results from a preliminary case-control and therapeutic study. Am J Gastroenterol 2003, 98:625-629.
27. Nachman F., Vazquez H., Gonzalez A., et al. Gastroesophageal reflux symptoms in patients with celiac disease and the effects of a gluten-free diet. Clin Gastroenterol Hepatol 2011, 9:214-219.
28. Meyer D., Stavropolous S., Diamond B., et al. Osteoporosis in a North American adult population with celiac disease. Am J Gastroenterol 2001, 96:112-119.
29. Brar P., Kwon G.Y., Holleran S., et al. Change in lipid profile in celiac disease: beneficial effect of gluten-free diet. Am J Med 2006, 119:786-790.
30. NIH Consensus Development Conference on Celiac Disease. NIH Consens State Sci Statements 2004, 21:1-23.
31. NICE clinical guideline CG86: Coeliac disease: recognition and assessment of coeliac disease. (Available at:). Accessed August 9, 2012. http://www.nice.org.uk/CG86.
32. Hill I.D., Dirks M.H., Liptak G.S., et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005, 40:1-19.
33. Husby S., Koletzko S., Korponay-Szabo I.R., et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012, 54:136-160.
34. Rashtak S., Ettore M.W., Homburger H.A., et al. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease. Clin Gastroenterol Hepatol 2008, 6:426-432. [quiz: 370].
35. Dieterich W., Ehnis T., Bauer M., et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997, 3:797-801.
36. Schuppan D., Junker Y., Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009, 137:1912-1933.
37. Li M., Yu L., Tiberti C., et al. A report on the International Transglutaminase Autoantibody Workshop for Celiac Disease. Am J Gastroenterol 2009, 104:154-163.
38. Sblattero D., Berti I., Trevisiol C., et al. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol 2000, 95:1253-1257.
39. Rostom A., Murray J.A., Kagnoff M.F. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006, 131:1981-2002.
40. Chorzelski T.P., Sulej J., Tchorzewska H., et al. IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann N Y Acad Sci 1983, 420:325-334.
41. Karpati S., Stolz W., Meurer M., et al. Extracellular binding sites of IgA anti-jejunal antibodies on normal small bowel detected by indirect immunoelectronmicroscopy. J Invest Dermatol 1991, 96:228-233.
42. Ladinser B., Rossipal E., Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut 1994, 35:776-778.
43. Volta U., Molinaro N., Fratangelo D., et al. IgA antibodies to jejunum. Specific immunity directed against target organ of gluten-sensitive enteropathy. Dig Dis Sci 1994, 39:1924-1929.
44. Kurppa K., Collin P., Viljamaa M., et al. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology 2009, 136:816-823.
45. van der Windt D.A., Jellema P., Mulder C.J., et al. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA 2010, 303:1738-1746.
46. Walker M.M., Murray J.A., Ronkainen J., et al. Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology 2010, 139:112-119.
47. Midhagen G., Aberg A.K., Olcen P., et al. Antibody levels in adult patients with coeliac disease during gluten-free diet: a rapid initial decrease of clinical importance. J Intern Med 2004, 256:519-524.
48. Sollid L.M. Molecular basis of celiac disease. Annu Rev Immunol 2000, 18:53-81.
49. Sollid L.M., Markussen G., Ek J., et al. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 1989, 169:345-350.
50. Kaukinen K., Partanen J., Maki M., et al. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol 2002, 97:695-699.
51. *02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003, 64:469-477.
52. Romanos J., van Diemen C.C., Nolte I.M., et al. Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease. Gastroenterology 2009, 137:834-840. 840.e1-3.
53. Hadithi M., von Blomberg B.M., Crusius J.B., et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med 2007, 147:294-302.
54. Rubio-Tapia A., Rahim M.W., See J.A., et al. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol 2010, 105:1412-1420.
55. Iltanen S., Holm K., Partanen J., et al. Increased density of jejunal gammadelta+ T cells in patients having normal mucosa-marker of operative autoimmune mechanisms?. Autoimmunity 1999, 29:179-187.
56. Shah V.H., Rotterdam H., Kotler D.P., et al. All that scallops is not celiac disease. Gastrointest Endosc 2000, 51:717-720.
57. Dickey W., Hughes D. Disappointing sensitivity of endoscopic markers for villous atrophy in a high-risk population: implications for celiac disease diagnosis during routine endoscopy. Am J Gastroenterol 2001, 96:2126-2128.
58. Harewood G.C., Holub J.L., Lieberman D.A. Variation in small bowel biopsy performance among diverse endoscopy settings: results from a national endoscopic database. Am J Gastroenterol 2004, 99:1790-1794.
59. Lebwohl B., Tennyson C., Holub J.L., et al. Gender and racial disparities in duodenal biopsy for the diagnosis of celiac disease. Am J Gastroenterol 2011, 106:S82-S83.
60. Mukherjee R., Egbuna I., Brar P., et al. Celiac disease: similar presentations in the elderly and young adults. Dig Dis Sci 2010, 55:3147-3153.
61. Pais W.P., Duerksen D.R., Pettigrew N.M., et al. How many duodenal biopsy specimens are required to make a diagnosis of celiac disease?. Gastrointest Endosc 2008, 67:1082-1087.
62. Lebwohl B., Kapel R.C., Neugut A.I., et al. Adherence to biopsy guidelines increases celiac disease diagnosis. Gastrointest Endosc 2011, 74:103-109.
63. Gonzalez S., Gupta A., Cheng J., et al. Prospective study of the role of duodenal bulb biopsies in the diagnosis of celiac disease. Gastrointest Endosc 2010, 72:758-765.
64. Arguelles-Grande C., Tennyson C.A., Lewis S.K., et al. Variability in small bowel histopathology reporting between different pathology practice settings: impact on the diagnosis of coeliac disease. J Clin Pathol 2012, 65(3):242-247. [Epub 2011 Nov 12].
65. Catassi C., Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med 2010, 123:691-693.
66. Verdu E.F., Armstrong D., Murray J.A. Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity. Am J Gastroenterol 2009, 104:1587-1594.
67. Berger E., Buergin-Wolff A., Freudenberg E. Klin Wochenschr 1964, 42:788-790. [in German].
68. Seah P.P., Fry L., Rossiter M.A., et al. Anti-reticulin antibodies in childhood coeliac disease. Lancet 1971, 2:681-682.
69. Chorzelski T.P., Beutner E.H., Sulej J., et al. IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease. Br J Dermatol 1984, 111:395-402.
70. Guandalini S., Ventura A., Ansaldi N., et al. Diagnosis of coeliac disease: time for a change?. Arch Dis Child 1989, 64:1320-1324. [discussion: 4-5].
71. Walker-Smith J.A., Guandalini S., Schmitz J., et al. Revised criteria for diagnosis of coeliac disease. Report of a Working Group of ESPGAN. Arch Dis Child 1990, 65:909-911.
72. Schoenfeld P., Guyatt G., Hamilton F., et al. An evidence-based approach to gastroenterology diagnosis. Gastroenterology 1999, 116:1230-1237.
73. Wong R.C., Wilson R.J., Steele R.H., et al. A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol 2002, 55:488-494.
74. Hill P.G., McMillan S.A. Anti-tissue transglutaminase antibodies and their role in the investigation of coeliac disease. Ann Clin Biochem 2006, 43:105-117.
75. Collin P., Kaukinen K., Vogelsang H., et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol 2005, 17:85-91.
76. Aleanzi M., Demonte A.M., Esper C., et al. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides. Clin Chem 2001, 47:2023-2028.
77. Schwertz E., Kahlenberg F., Sack U., et al. Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease. Clin Chem 2004, 50:2370-2375.
78. Vermeersch P., Geboes K., Marien G., et al. Diagnostic performance of IgG anti-deamidated gliadin peptide antibody assays is comparable to IgA anti-TTG in celiac disease. Clin Chim Acta 2010, 411:931-935.
79. Villalta D., Tonutti E., Prause C., et al. IgG antibodies against deamidated gliadin peptides for diagnosis of celiac disease in patients with IgA deficiency. Clin Chem 2010, 56:464-468.
80. Barbato M., Maiella G., Di Camillo C., et al. The anti-deamidated gliadin peptide antibodies unmask celiac disease in small children with chronic diarrhoea. Dig Liver Dis 2011, 43:465-469.
81. Monzani A., Rapa A., Fonio P., et al. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease. J Pediatr Gastroenterol Nutr 2011, 53:55-60.
82. Mubarak A., Gmelig-Meyling F.H., Wolters V.M., et al. Immunoglobulin G antibodies against deamidated-gliadin-peptides outperform anti-endomysium and tissue transglutaminase antibodies in children <2 years age. APMIS 2011, 119:894-900.
83. Liu E., Li M., Emery L., et al. Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease. J Pediatr Gastroenterol Nutr 2007, 45:293-300.
84. Nachman F., Sugai E., Vazquez H., et al. Serological tests for celiac disease as indicators of long-term compliance with the gluten-free diet. Eur J Gastroenterol Hepatol 2011, 23:473-480.
85. Kurppa K., Lindfors K., Collin P., et al. Antibodies against deamidated gliadin peptides in early-stage celiac disease. J Clin Gastroenterol 2011, 45:673-678.
86. Parakkal D., Du H., Semer R., et al. Do gastroenterologists adhere to diagnostic and treatment guidelines for celiac disease?. J Clin Gastroenterol 2012, 46:e12-e20.
87. Diamanti A., Colistro F., Calce A., et al. Clinical value of immunoglobulin A antitransglutaminase assay in the diagnosis of celiac disease. Pediatrics 2006, 118:e1696-e1700.
88. Barker C.C., Mitton C., Jevon G., et al. Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations?. Pediatrics 2005, 115:1341-1346.
89. Alessio M., Tonutti E., Brusca I., et al. Correlation between IgA tissue transglutaminase antibody ratio and histological finding in celiac disease: a multicentre study. J Pediatr Gastroenterol Nutr 2012, 55(1):44-49.
90. Basso D., Guariso G., Bozzato D., et al. New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. Clin Chim Acta 2011, 412:1662-1667.
91. Sugai E., Moreno M.L., Hwang H.J., et al. Celiac disease serology in patients with different pretest probabilities: is biopsy avoidable?. World J Gastroenterol 2010, 16:3144-3152.
92. Kurppa K., Ashorn M., Iltanen S., et al. Celiac disease without villous atrophy in children: a prospective study. J Pediatr 2010, 157:373-380. 380.e1.
93. Tosco A., Salvati V.M., Auricchio R., et al. Natural history of potential celiac disease in children. Clin Gastroenterol Hepatol 2011, 9:320-325. [quiz: e36].
94. Rozenberg O., Lerner A., Pacht A., et al. A new algorithm for the diagnosis of celiac disease. Cell Mol Immunol 2011, 8:146-149.
95. Fernandez-Banares F., Alsina M., Modolell I., et al. Are positive serum-IgA-tissue-transglutaminase antibodies enough to diagnose coeliac disease without a small bowel biopsy? Post-test probability of coeliac disease. J Crohns Colitis 2012, 6:861-866.